A.   Continue to monitor consciousness for 2 minutes.

B.   Administer four doses at 15-second intervals.

C.   Administer a second dose.

D.   Provide another prescribed medication.

A.   Eszopiclone

B.   Zolpidem

C.   Ramelteon

D.   Zaleplon

A.   Sleepwalking

B.   Dozing

C.   Deep sleep

D.   Relaxation

A.   Sleepwalking

B.   Daytime fatigue

C.   Vivid dreams

D.   Bedwetting

A.   Ultra-short-acting barbiturates

B.   Short-acting barbiturates

C.   Intermediate-acting barbiturates

D.   Long-acting barbiturates

A.   Cardiac disease

B.   Epileptic disease

C.   Drug allergy

D.   Narrow-angle glaucoma

A.   Reduction of choreiform movement

B.   Relief of nerve pain

C.   Reduction of muscle rigidity

D.   Prevention of lightheadedness

A.   Increased body weight

B.   Bedwetting

C.   Sleepwalking

D.   Increased perspiration

A.   Eszopiclone

B.   Midazolam

C.   Ramelteon

D.   Alprazolam

A.   Cyclobenzaprine

B.   Dantrolene

C.   Baclofen

D.   Diazepam

A.   Decreased heart rate

B.   Constipation

C.   Amnesia

D.   Dry mouth

A.   Verapamil

B.   Olanzapine

C.   Rifampin

D.   Flumazenil

A.   The drug acts on gamma-aminobutyric acid (GABA) receptors in the central nervous system (CNS).

B.   The patient may need to be sedated to relieve symptoms of alcohol withdrawal.

C.   The drug acts on benzodiazepine receptors that play a role in alcohol addiction.

D.   The drug may reduce the memory of painful symptoms related to alcohol withdrawal.

A.   Oxytocin

B.   Sulfamethoxazole

C.   Ceftriaxone

D.   Phenobarbital

A.   Phenobarbital

B.   Butabarbital

C.   Mephobarbital

D.   Pentobarbital

A.   Prolonged benzodiazepine action

B.   Increased central nervous system (CNS) depression

C.   Increased daytime sleepiness

D.   Decreased benzodiazepine effects

A.   Olanzapine

B.   Furosemide

C.   Activated charcoal

D.   Flumazenil

A.   Amnesic properties

B.   Suppression of gamma-aminobutyric acid (GABA) receptors

C.   Inhibition of nerve impulse transmission

D.   Presence of benzodiazepine receptors adjacent to the receptors responsible for alcohol addiction

A.   Teaching the patient about meditation

B.   Encouraging the patient to maintain a well-balanced diet

C.   Instructing the patient to take low doses of benzodiazepines

D.   Recommending that the patient consume a glass of warm lactose-free milk at bedtime

A.   Flumazenil at a maximum dose of 3 mg

B.   Phenylephrine at a maximum dose of 5 mg

C.   Phenylephrine at a maximum dose of 2 mg

D.   Flumazenil at a maximum dose of 1 mg

A.   The patient is experiencing a barbiturate overdose.

B.   The patient was administered azole along with benzodiazepine.

C.   The patient is experiencing a muscle-relaxant overdose.

D.   The patient is experiencing benzodiazepine toxicity.

A.   Zaleplon

B.   Diazepam

C.   Ramelteon

D.   Pentobarbital

A.   Avoiding alcohol at bedtime

B.   Avoiding tobacco at bedtime

C.   Establishing a set sleep pattern

D.   Sleeping more during the day

A.   Diazepam

B.   Temazepam

C.   Midazolam

D.   Flurazepam

A.   Hallucinations

B.   Alertness

C.   Ataxia

D.   Dyspnea

A.   Naloxone

B.   Ipecac syrup

C.   Activated charcoal

D.   Flumazenil

A.   Degree of inhibition of nerve impulse transmission to the CNS

B.   Dose of the drug used to produce the effect on the CNS

C.   Duration of action on the central nervous system (CNS)

D.   Degree of patient responsiveness to the drug given

A.   Temazepam induces sleep in approximately 1 hour.

B.   The therapeutic activity of temazepam is reduced with sleep.

C.   Temazepam causes early awakening after sleep.

D.   Temazepam may cause gastrointestinal upset.

A.   Infusion of other drugs

B.   Infusion that is too rapid

C.   Intravenous infiltration

D.   Infusion without dilution

A.   Drink lactose-free milk at bedtime.

B.   Go to acupuncture therapy.

C.   Take lower doses of benzodiazepines.

D.   Use home remedies of vegetables and herbs.

A.   Diazepam, Ramelteon, Midazolam

B.   Zolpidem, Diazepam, Midazolam

C.   Diazepam, Midazolam, Eszopiclone

D.   Zolpidem, Ramelteon, Eszopiclone

A.   Administration of furosemide

B.   Maintenance of an adequate airway

C.   Administration of activated charcoal

D.   Administration of intravenous fluids

A.   "I will have a glass of warm milk before bed."

B.   "I will stop drinking coffee at least 6 hours before bedtime."

C.   "I should avoid exercise just before going to bed."

D.   "I may be prescribed benzodiazepines to promote sleep."

A.   Suggest an alternate contraceptive method to the patient.

B.   Request a prescription to increase the dosage of pentobarbital.

C.   Recommend discussing an alternative drug for seizures with the primary health care provider.

D.   Instruct the patient to increase the dosage of the contraceptive drug.

A.   Tonic-clonic seizure

B.   Respiratory arrest

C.   Malignant hyperthermia

D.   Delirium tremens

A.   Avoid using this drug to induce sleep.

B.   Drink coffee or tea in the morning.

C.   Take the drug 30 minutes before sleeping.

D.   Use the lowest effective dosage.

A.   Impairs coordinated movements

B.   Increases pain associated with activities

C.   Produces drowsiness, lethargy, and blurred vision

D.   Causes gastrointestinal distress

A.   Pentobarbital

B.   Butabarbital

C.   Thiopental

D.   Phenobarbital

A.   Significant respiratory difficulties, Hypotension, Status epilepticus

B.   Hypotension, Drug allergy, Status epilepticus

C.   Pregnancy, Drug allergy, Significant respiratory difficulties

D.   Hypotension, Status epilepticus, Pregnancy

A.   "Allow at least 8 hours for sleep."

B.   "Expect and prepare for a daytime hangover."

C.   "Report palpitations to the primary health care provider."

D.   "Take the medication with food or milk."

A.   Takes phenobarbital along with diazepam

B.   Drinks grapefruit juice along with diazepam

C.   Takes rifampin along with diazepam

D.   Takes olanzapine along with diazepam

A.   Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI), Atypical antidepressants

B.   Selective serotonin reuptake inhibitor (SSRI), Tricyclic antidepressant, Serotonin-norepinephrine reuptake inhibitor (SNRI)

C.   Tricyclic antidepressant, Monoamine oxidase inhibitor (MAOI), Atypical antidepressants

D.   Monoamine oxidase inhibitor (MAOI), Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI)

A.   Liver dysfunction

B.   Narrow-angle glaucoma

C.   Kidney dysfunction

D.   Bronchial asthma

A.   Alprazolam

B.   Eszopiclone

C.   Temazepam

D.   Clonazepam

A.   Pentobarbital

B.   Zaleplon

C.   Baclofen

D.   Diazepam

A.   Monitoring for suicidal tendencies

B.   Monitoring the patient’s renal and hepatic function

C.   Encouraging the patient to drink more fluids

D.   Assessing the patient’s risk for injury or falls

A.   Seizure precautions

B.   Comfort measures

C.   Airway maintenance

D.   Antidote preparation

A.   Muscle spasms

B.   Level of consciousness

C.   Amount of bleeding

D.   Indicators of infection

A.   A high dose of flumazenil was given.

B.   The half-life of flumazenil is short.

C.   0.2 mg (2 mL) of flumazenil was given intravenously (IV).

D.   Alcohol was consumed with the benzodiazepines.

A.   Zaleplon

B.   Ramelteon

C.   Alprazolam

D.   Eszopiclone

A.   "I often feel dizzy and lightheaded."

B.   "I sleep less than I used to."

C.   "I feel like I breathe too deeply."

D.   "Nowadays I sleep for long hours."

A.   0.5 mg (5 mL) IV over 30 seconds

B.   0.2 mg (2 mL) intravenously (IV) over 30 seconds

C.   0.2 mg (2 mL) IV over 15 seconds

D.   0.2 mg (2 mL) IV over 60 seconds